⌘K

Login Start Free

Home/Filings/4/0001387131-15-000874

4//SEC Filing

Ohr Pharmaceutical Inc 4

Accession 0001387131-15-000874

CIK 0001173281operating

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:34 PM ET

Size

9.7 KB

Accession

0001387131-15-000874

Insider Transaction Report

Form 4

Period: 2015-03-10

Ohr Pharmaceutical IncOHRP

Director10% Owner

Transactions

Award
Option
2015-03-10+84,000→ 84,000 total
Exercise: $10.14From: 2015-03-10Exp: 2020-03-10→ Common Stock (84,000 underlying)

Holdings

Common Stock, $0.0001 par value
(indirect: By Children)
138,200
Option
Exercise: $1.71From: 2012-03-09Exp: 2017-03-09→ Common Stock (100,000 underlying)
100,000
Common Stock, $0.0001 par value
(indirect: By LLC)
1,506,747
Warrant
(indirect: By LLC)
Exercise: $3.60From: 2012-06-28Exp: 2017-06-28→ Common Stock (29,000 underlying)
29,000

Footnotes (2)

[F1]63,000 options are currently unexercisable; 1/3rd will become exercisable on each of March 10, 2016, March 10, 2017 and March 10, 2018.
[F2]Options granted pursuant to registrant's 2014 Stock Incentive Plan.

Documents

1 file

4
hirschman-form4_031015.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Ohr Pharmaceutical Inc

CIK 0001173281

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001173281

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 4:34 PM ET
Size: 9.7 KB

View on SEC.gov